Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study

Aims/hypothesisOutcome data on individuals with diabetic foot ulcers are scarce, especially in those with peripheral arterial disease (PAD). We therefore examined the clinical characteristics that best predict poor outcome in a large population of diabetic foot ulcer patients and examined whether such predictors differ between patients with and without PAD.MethodsAnalyses were conducted within the EURODIALE Study, a prospective cohort study of 1,088 diabetic foot ulcer patients across 14 centres in Europe. Multiple logistic regression modelling was used to identify independent predictors of outcome (i.e. non-healing of the foot ulcer).ResultsAfter 1 year of follow-up, 23% of the patients had not healed. Independent baseline predictors of non-healing in the whole study population were older age, male sex, heart failure, the inability to stand or walk without help, end-stage renal disease, larger ulcer size, peripheral neuropathy and PAD. When analyses were performed according to PAD status, infection emerged as a specific predictor of non-healing in PAD patients only.Conclusions/interpretationPredictors of healing differ between patients with and without PAD, suggesting that diabetic foot ulcers with or without concomitant PAD should be defined as two separate disease states. The observed negative impact of infection on healing that was confined to patients with PAD needs further investigation.

[1]  L. Wong,et al.  Surgical infections in patients with chronic renal failure. , 2001, Infectious disease clinics of North America.

[2]  M. Huijberts,et al.  Casting of recurrent diabetic foot ulcers: effective and safe? , 2005, Diabetes care.

[3]  T. Lehtimäki,et al.  The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  A. Boulton.  The Pathogenesis of Diabetic Foot Problems: an Overview , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[5]  Jesse A Berlin,et al.  Diabetic neuropathic foot ulcers: predicting which ones will not heal. , 2003, The American journal of medicine.

[6]  L. Uccioli,et al.  High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study , 2006, Diabetologia.

[7]  W. Jeffcoate,et al.  The association between baseline characteristics and the outcome of foot lesions in a UK population with diabetes , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[8]  H. Boshuizen,et al.  Multiple imputation of missing blood pressure covariates in survival analysis. , 1999, Statistics in medicine.

[9]  J Larsson,et al.  Long-Term Costs for Foot Ulcers in Diabetic Patients in a Multidisciplinary Setting , 1995, Foot & ankle international.

[10]  David G Armstrong,et al.  Validation of a Diabetic Wound Classification System: The contribution of depth, infection, and ischemia to risk of amputation , 1998, Diabetes Care.

[11]  L. Harkless,et al.  An open-label, randomized study comparing efficacy and safety of intravenous piperacillin/tazobactam and ampicillin/sulbactam for infected diabetic foot ulcers. , 2005, Surgical infections.

[12]  D. Armstrong,et al.  Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial , 2005, The Lancet.

[13]  Anthony Delitto,et al.  Total Contact Casting in Treatment of Diabetic Plantar Ulcers: Controlled Clinical Trial , 1989, Diabetes Care.

[14]  É. Allaire,et al.  Foot Gangrene in Patients with End-Stage Renal Disease: A Case Control Study , 2006, Angiology.

[15]  Patrick Royston,et al.  Multiple Imputation of Missing Values: Update of Ice , 2005 .

[16]  N. Schaper,et al.  The effect of diabetes and severe ischaemia on the penetration of ceftazidime into tissues of the limb , 2001, Diabetic Medicine.

[17]  Karel Bakker,et al.  Optimal Organization of Health Care in Diabetic Foot Disease: Introduction to the Eurodiale Study , 2007, The international journal of lower extremity wounds.

[18]  N. Schaper,et al.  International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. , 2000, Diabetes/metabolism research and reviews.

[19]  P. Hoffert,et al.  Study of vascular lesions in diabetic, nondiabetic patients. Clinical, arteriographic, and surgical considerations. , 1965, Archives of Surgery.

[20]  H. Ochs,et al.  Increased risk of lower-extremity amputation among Caucasian diabetic patients on dialysis. , 2001, Diabetes care.

[21]  M. Huijberts,et al.  Health-related quality of life of diabetic foot ulcer patients and their caregivers , 2005, Diabetologia.

[22]  C. Wicke,et al.  A New Wound-Based Severity Score for Diabetic Foot Ulcers , 2006, Diabetes Care.

[23]  G. Salles,et al.  Macro and microvascular complications are determinants of increased infection-related mortality in Brazilian type 2 diabetes mellitus patients. , 2007, Diabetes Research and Clinical Practice.

[24]  Ning Li,et al.  Tools for Analyzing Multiple Imputed Datasets , 2003 .

[25]  D. Armstrong,et al.  Preventing foot ulcers in patients with diabetes. , 2005, JAMA.

[26]  A. Shirai,et al.  Risk factors for major limb amputations in diabetic foot gangrene patients. , 2006, Diabetes research and clinical practice.

[27]  Roderick J. A. Little.  Regression with Missing X's: A Review , 1992 .

[28]  I Tarawneh,et al.  The effects of ulcer size and site, patient's age, sex and type and duration of diabetes on the outcome of diabetic foot ulcers , 2001, Diabetic medicine : a journal of the British Diabetic Association.

[29]  U. Persson,et al.  Diabetic foot ulcers in a multidisciplinary setting An economic analysis of primary healing and healing with amputation , 1994, Journal of internal medicine.

[30]  M. Huijberts,et al.  Total contact casting of the diabetic foot in daily practice: a prospective follow-up study. , 2005, Diabetes care.

[31]  DOUGLAS G. Smith,et al.  Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. , 2002, The Journal of surgical research.

[32]  N. Schaper,et al.  International consensus and practical guidelines on the management and the prevention of the diabetic foot , 2000, Current diabetes reports.

[33]  Floyd,et al.  Cellular changes in denervated tissue during wound healing in a rat model , 1999, British Journal of Dermatology.

[34]  A. Jirkovska,et al.  Comparison of microbial findings and resistance to antibiotics between transplant patients, patients on hemodialysis, and other patients with the diabetic foot. , 2004, Journal of diabetes and its complications.

[35]  Stephanie Wu,et al.  Evaluation of removable and irremovable cast walkers in the healing of diabetic foot wounds: a randomized controlled trial. , 2005, Diabetes care.

[36]  S. Rajagopalan,et al.  Peripheral Arterial Disease in Patients With End-Stage Renal Disease: Observations From the Dialysis Outcomes and Practice Patterns Study (DOPPS) , 2006, Circulation.

[37]  N. Schaper,et al.  Diabetic foot ulcer classification system for research purposes: a progress report on criteria for including patients in research studies , 2004, Diabetes/Metabolism Research Reviews.

[38]  J. Apelqvist,et al.  Health-economic consequences of diabetic foot lesions. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.